🟢 Citius Pharmaceuticals is trading 9.14% up in after-hours trading with no clear company-specific catalyst identified

Citius Pharmaceuticals is trading at $0.59, up 9.14%, in after-hours trading; no clear company-specific catalyst was identified for the November 6, 2026 move.

• Citius Oncology announced positive LYMPHIR quality-of-life results on November 4, but the available report does not link them to the November 6 move.
• The results were exploratory and descriptive; the study was not designed or powered to evaluate quality-of-life outcomes. Trading volume or activity data was unavailable.